Safety Study of FP-1039 To Treat Cancer
The primary purpose of this study is to evaluate the safety and tolerability of FP-1039, a new biologic treatment for cancer.
Advanced Cancer
DRUG: FP-1039
Safety and tolerability, 4 weeks
The primary purpose of this study is to evaluate the safety and tolerability of FP-1039, a new biologic treatment for cancer.